SELECTIVE ISOLATION OF TRANSFORMED BREAST EPITHELIUM

选择性分离转化的乳腺上皮

基本信息

项目摘要

Our major goal in this proposal is to use novel culture conditions to achieve high-frequency selection and proliferation of transformed cells from (a) clinical specimens of breast carcinoma, and (b) cultures of human mammary epithelial cells (HMEC) after exposure to chemical carcinogens. Limitations in presently used protocols have significantly hampered progress in this area. Our novel approach will be to expose the mixture of normal cells and putative transformants (which is inevitable in both (a) and (b)above) to conditions which closely simulate the microenvironment of solid tumors. In this regard, the literature provides strong suggestive evidence that, due to an imbalance of tumor growth and vascularization, gradients of O2 and nutrients are formed even during very early stages of neoplasia. We hypothesize that neoplastic or transformed cells may harbor genetic and/or epigenetic changes which enable them to survive under these conditions and to acquire progressive alterations essential for subsequent stages of tumor progression. In culture, this altered responsiveness to the environment could provide the putative transformants selective expansion advantage over the surrounding normal cells, much the same way as it is thought to occur in vivo. We will test our hypothesis in a culture system in which anchorage-dependent cells can be subjected to self-created gradients of O2 and glucose. Moreover, we will determine relative transformation frequency in immunomagnetically separated populations of the luminal and basal subsets of the human mammary gland as well as in HMEC from ductal versus lobular areas of the mammary tree. We will use this novel culture system to ask whether the yield of experimentally-induced transformation is higher in HMEC derived from non-malignant mastectomy tissue including specimens from patients at a high risk of familial breast cancer. The innovative approach proposed in this application can provide an invaluable framework for the selective isolation of tumor cells from primary breast carcinoma tissue in order to facilitate studies on the early stages of malignant progression. Additionally, it will provide the opportunity to delineate markers that represent specific stages of in vitro and in vivo mammary epithelial transformation and to identify the most susceptible target cells. Most importantly, this study may provide a rapid means for investigating which chemical or physical agents alone or in combination are able to enhance or reduce transformation frequency, thereby facilitating studies on the etiology and mechanisms of carcinogenesis in epithelial cells of other tissues as well.
我们的主要目标是利用新的培养条件, 实现转化细胞的高频率选择和增殖, 来自(a)乳腺癌的临床样本,和(B)人的培养物 乳腺上皮细胞(HMEC)暴露于化学致癌物后。 目前使用的协议的局限性严重阻碍了 这方面的进展。 我们的新方法是将混合物 正常细胞和假定的转化体(这是不可避免的, (a)和(B)以上)的条件下, 实体瘤的微环境。在这方面,文献提供了 强有力的证据表明,由于肿瘤生长的不平衡, 血管化,梯度的O2和营养素形成,即使在非常 早期肿瘤我们假设肿瘤或转化 细胞可能具有遗传和/或表观遗传变化, 在这些条件下生存,并获得渐进的变化 对于肿瘤进展的后续阶段至关重要。在文化中,这 对环境的反应性改变可以提供假定的 转化体选择性扩增优于周围正常 细胞,就像它被认为是在体内发生的一样。我们将测试 我们假设在一个培养系统中,贴壁依赖性细胞可以 会受到氧气和葡萄糖的自发梯度的影响。而且我们 将确定免疫磁性中的相对转化频率 人的管腔和基底亚群的分离群体 乳腺以及HMEC的导管与小叶区域 乳腺树我们将用这个新的文化系统来问, 实验诱导转化的产率在HMEC中更高, 来自非恶性乳房切除组织,包括来自患者的样本, 家族性乳腺癌的高风险。 本申请中提出的创新方法可以提供 选择性分离肿瘤细胞的宝贵框架, 原发性乳腺癌组织,以便于研究 恶性进展的早期阶段此外,它还将提供 有机会描绘代表特定阶段的标记, 体外和体内乳腺上皮转化,并确定 最敏感的靶细胞。最重要的是,这项研究可以提供一个 快速调查哪些化学或物理制剂单独或 组合能够提高或降低转化频率, 从而有助于研究的病因和机制, 在其他组织的上皮细胞中也是致癌的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHANAZ H DAIRKEE其他文献

SHANAZ H DAIRKEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHANAZ H DAIRKEE', 18)}}的其他基金

Functional Analysis of Histologic Grade in Breast Cancer
乳腺癌组织学分级的功能分析
  • 批准号:
    6928184
  • 财政年份:
    2005
  • 资助金额:
    $ 19.86万
  • 项目类别:
Functional Analysis of Histologic Grade in Breast Cancer
乳腺癌组织学分级的功能分析
  • 批准号:
    7048680
  • 财政年份:
    2005
  • 资助金额:
    $ 19.86万
  • 项目类别:
Functional Analysis of Histologic Grade in Breast Cancer
乳腺癌组织学分级的功能分析
  • 批准号:
    7363709
  • 财政年份:
    2005
  • 资助金额:
    $ 19.86万
  • 项目类别:
Functional Analysis of Histologic Grade in Breast Cancer
乳腺癌组织学分级的功能分析
  • 批准号:
    7210544
  • 财政年份:
    2005
  • 资助金额:
    $ 19.86万
  • 项目类别:
Functional Analysis of Histologic Grade in Breast Cancer
乳腺癌组织学分级的功能分析
  • 批准号:
    7578880
  • 财政年份:
    2005
  • 资助金额:
    $ 19.86万
  • 项目类别:
CORE--CELL BIOLOGY
核心--细胞生物学
  • 批准号:
    6311515
  • 财政年份:
    1999
  • 资助金额:
    $ 19.86万
  • 项目类别:
CORE--CELL BIOLOGY
核心--细胞生物学
  • 批准号:
    6102378
  • 财政年份:
    1999
  • 资助金额:
    $ 19.86万
  • 项目类别:
CORE--CELL BIOLOGY
核心--细胞生物学
  • 批准号:
    6269287
  • 财政年份:
    1998
  • 资助金额:
    $ 19.86万
  • 项目类别:
CORE--CELL BIOLOGY
核心--细胞生物学
  • 批准号:
    6236899
  • 财政年份:
    1997
  • 资助金额:
    $ 19.86万
  • 项目类别:
SELECTIVE ISOLATION OF TRANSFORMED BREAST EPITHELIUM
选择性分离转化的乳腺上皮
  • 批准号:
    2110550
  • 财政年份:
    1994
  • 资助金额:
    $ 19.86万
  • 项目类别:

相似国自然基金

基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 批准年份:
    2016
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 批准年份:
    2011
  • 资助金额:
    50.0 万元
  • 项目类别:
    面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

Comprehensive genetic analysis-based liquid biopsy for establishment of the novel tumor biomarker in dog
基于综合遗传分析的液体活检建立狗的新型肿瘤生物标志物
  • 批准号:
    21K05952
  • 财政年份:
    2021
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Towards a Virtual Biopsy: An improved multimodal imaging biomarker to guide treatment decisions in neuro-oncology by combining advanced tissue microstructure imaging with deep learning
走向虚拟活检:一种改进的多模态成像生物标志物,通过将先进的组织微观结构成像与深度学习相结合来指导神经肿瘤学的治疗决策
  • 批准号:
    10325327
  • 财政年份:
    2021
  • 资助金额:
    $ 19.86万
  • 项目类别:
Study for novel biomarker in liquid biopsy on on carcinogenic pathways induced by driver mutations
液体活检中驱动突变诱发致癌途径的新型生物标志物研究
  • 批准号:
    20K07671
  • 财政年份:
    2020
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of liquid biopsy biomarker for precision neoadjuvant treatment for pancreatic cancer
胰腺癌精准新辅助治疗液体活检生物标志物的开发
  • 批准号:
    20K22861
  • 财政年份:
    2020
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Novel Multiplex Biomarker Discovery Methods To Predict Breast Cancer Risk After A Benign Biopsy
良性活检后预测乳腺癌风险的新型多重生物标志物发现方法
  • 批准号:
    10021604
  • 财政年份:
    2019
  • 资助金额:
    $ 19.86万
  • 项目类别:
Clinical significance of liquid biopsy using a novel biomarker for sarcoma
使用新型肉瘤生物标志物进行液体活检的临床意义
  • 批准号:
    19K09650
  • 财政年份:
    2019
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biomarker screening of urothelial carcinoma using liquid biopsy
使用液体活检进行尿路上皮癌生物标志物筛查
  • 批准号:
    19K18575
  • 财政年份:
    2019
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The search of biomarker for the liquid-biopsy to diagnose the cellular infiltration in the kidney injury
液体活检诊断肾损伤细胞浸润生物标志物的探索
  • 批准号:
    18K05996
  • 财政年份:
    2018
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of kidney cancer biomarker for therapeutic efficacy by using imaging and liquid biopsy
利用成像和液体活检开发肾癌生物标志物以提高治疗效果
  • 批准号:
    18K16719
  • 财政年份:
    2018
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New biomarker for recurrence of HCC by using liquid biopsy
通过液体活检发现 HCC 复发的新生物标志物
  • 批准号:
    17K10678
  • 财政年份:
    2017
  • 资助金额:
    $ 19.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了